Acute myeloid leukemia is clinically known as acute myeloid leukemia, which requires individualized treatment according to the patient’s disease typing, staging and patient’s condition, including supportive therapy, chemotherapy, targeted drug therapy, stem cell transplantation and so on.
1. Supportive therapy: Including preventing and treating infection (levofloxacin), treating hyperleukemia (leukocyte mono-collection), correcting anemia (red blood cell transfusion), preventing bleeding (aminoglycolic acid) and other supportive therapies.
2. Chemotherapy: According to the type of primitive cells, chemotherapy is divided into two kinds, one of which is AML treatment for non-acute promyelocytic leukemia, based on anthracycline drugs combined with cytarabine, and commonly used drugs are desmethoxylated erythromycin or erythromycin. The second is the treatment of acute promyelocytic leukemia, the main drugs used are all-trans retinoic acid, arsenic and so on.
3. Targeted drug therapy: the main drugs include venetoclax, grafting, etc., and young patients often need to be combined with chemotherapy programs.
4. Stem cell transplantation: mainly includes allogeneic stem cell transplantation and autologous stem cell transplantation.
If patients are diagnosed with acute myeloid leukemia, they should follow the doctor’s instructions and take active treatment. After active and standardized treatment, most of the patients can survive for a long time, and patients should not take medication on their own, so as to avoid adverse reactions and aggravation of the condition.